F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding F-star Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 37 | 43 | +6 |
| Shares | 9.82M | 10.6M | +780.4K (+7.9%) |
| Value | $71.9M | $53.2M | −$18.6M (−25.9%) |
New holders (11)
Institutions that held F-star Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,834,360 | $9.21M | 5.02% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3.01M | 0.28% |
| Anson Funds Management LP | 309,703 | $1.55M | 0.21% |
| Jump Financial, LLC | 24,400 | $122.0K | 0.01% |
| Susquehanna International Group, LLP | 14,251 | $72.0K | 0.00% |
| Engineers Gate Manager LP | 10,700 | $54.0K | 0.00% |
| ExodusPoint Capital Management, LP | 10,854 | $54.0K | 0.00% |
| JPMorgan Chase & Co | 8,444 | $42.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 5,862 | $29.0K | 0.00% |
| Simplex Trading, LLC | 2,366 | $11.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 200 | $1.00K | 0.00% |
Sold out (5)
Institutions that held F-star Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boxer Capital, LLC | 1,751,428 | $12.8M |
| Monashee Investment Management LLC | 170,000 | $1.24M |
| Novo Holdings A/S | 2,703 | $20.0K |
| Bank of America Corp | 264 | $2.00K |
| Group One Trading, L.P. | 200 | $1.00K |